Cell line · CVCL_3798
SV-HUC-1
Transformed cell line, Homo sapiens. 41 papers.
4 sourcescell-lines-2026-11-14-0.1.0
Cite this record
ConductScience Library. SV-HUC-1. Cell lines, record CVCL_3798. Release cell-lines-2026-11-14-0.1.0, 14 Nov 2026. https://conductscience.org/library/cell-lines/CVCL_3798
On this page
Cell line
As Cellosaurus gives it.
- Name
- SV-HUC-1
- Accession
- CVCL_3798
- RRID
- RRID:CVCL_3798
- Synonyms
- HUC-1, SV-HUC, SVHUC
- Species
- Homo sapiens (Human)
- Sex
- Male
- Age at sampling
- 11Y
- Category
- Transformed cell line
- Derived from
- Ureter (in situ)
- Cell type
- Epithelial cell
- Entry created
- 2012-04-04
- Entry updated
- 2026-06-25
Source Cellosaurus
Problems0
Cellosaurus records no problem for this cell line.
None in this release.
Papers41
| Paper | Journal | Year | How we know | Retracted | Source |
|---|---|---|---|---|---|
| SESN2 promotes ferroptosis in bladder cancer by negatively regulating the NRF2/FSP1 signaling axis. | Transl Androl Urol | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Biophysical reprogramming of immunosuppressive neutrophils by cold atmospheric plasma reinvigorates antitumor immunity. | Sci Adv | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Reprogramming-driven Proteomic Shifts Mirror Bladder Cancer Progression and Reveal Biomarker Candidates Across Disease Grades. | Cancer Genomics Proteomics | 2026 | Its Methods give the RRID and name the line | PubMed | |
| O-GlcNAcylated TAP1 Impairs Antigen Presentation and Promotes Immune Evasion in Bladder Cancer. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
HSPB6: A Potential Prognostic Biomarker, Inhibiting the Epithelial-Mesenchymal Transition (EMT) Process Through the PI3K/Akt Signaling Pathway Based on the Machine Learning and Experimental Validation. | Hum Mutat | 2026 | Its Methods give the RRID and name the line | PubMed | |
| A 'two-in-one' tumor-specific-hydrogel-assisted strategy for intravesical chemotherapy and protection of normal tissues. | J Nanobiotechnology | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Proteomic Signatures of Cellular Reprogramming in Bladder Cancer: Insights into the Acquisition of Cancer Stem-like States and Phenotypic Plasticity. | Cancer Genomics Proteomics | 2026 | Its Methods give the RRID and name the line | PubMed | |
| m5C-Modified tRF3b-CysGCA-23 Suppresses Bladder Cancer Malignancy by Repressing H3K18 Lactylation via Stabilizing RBM4. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| FomA-Containing Outer Membrane Vesicles of Fusobacterium Nucleatum Facilitate Bladder Cancer Lymphatic Metastasis via IL-6-Dependent M2b Macrophage Polarization. | Adv Sci (Weinh) | 2026 | Its Methods give the RRID and name the line | PubMed | |
| Conjoining cell reprogramming and mass spectrometry to identify the proteomic variations in the reprogrammed bladder cancer cells: finding cues of normalisation. | BMC Cancer | 2026 | Its Methods give the RRID and name the line | PubMed |
1 to 10 of 41
See all 41 papersRelatives19
| Relation | Cell line | Accession | Problem | Source |
|---|---|---|---|---|
| Derived from it | EDITGENE SV-HUC-1-Cas9 | CVCL_F5QP | Cell lines | |
| Derived from it | EDITGENE SV-HUC-1-CopGFP | CVCL_F5ZJ | Cell lines | |
| Derived from it | EDITGENE SV-HUC-1-FLUC | CVCL_F5S2 | Cell lines | |
| Derived from it | MC-SV-HUC T-1 | CVCL_IP86 | Cell lines | |
| Derived from it | MC-SV-HUC T-10 | CVCL_IP89 | Cell lines | |
| Derived from it | MC-SV-HUC T-11 | CVCL_IP90 | Cell lines | |
| Derived from it | MC-SV-HUC T-16 | CVCL_IP91 | Cell lines | |
| Derived from it | MC-SV-HUC T-2 | CVCL_6418 | Cell lines | |
| Derived from it | MC-SV-HUC T-7 | CVCL_IP87 | Cell lines | |
| Derived from it | MC-SV-HUC T-9 | CVCL_IP88 | Cell lines |
1 to 10 of 19
See all 19 relativesCell banks6
Data dates
The date of each source this release read.
Sources 4
- CellosaurusCC BY 4.0, with credit to Cellosaurus (SIB)
- PubMed Central's articlesTitles shown only for CC0, CC BY and public domain articles
- NLM's PMC Article DatasetsCourtesy of NLM, which does not endorse this database
- PubMedNLM's terms
Each source's terms
- CellosaurusCC BY 4.0. Cellosaurus's README: "we have chosen to apply the Creative Commons Attribution 4.0 International (CC BY 4.0) license to Cellosaurus (https://creativecommons.org/licenses/by/4.0/). This means that you are free to copy and redistribute Cellosaurus in any medium or format. You can remix, transform, and build upon Cellosaurus for any purpose, even commercially. You must give appropriate credit, provide a link to the license, and indicate if changes were made." Copyright (c) CALIPHO group, SIB Swiss Institute of Bioinformatics. Read on 14 Nov 2026 at https://ftp.expasy.org/databases/cellosaurus/README
- PubMed Central's articlesEach article's own license. Its words show only under CC0, CC BY or public domain
- NLM's PMC Article DatasetsNLM's PMC Article Datasets on AWS, https://registry.opendata.aws/ncbi-pmc. Its terms: users "acknowledge NLM as the source of the data in a clear and conspicuous manner", do not use the PubMed Central wordmark or the PMC logo, do not "indicate or imply that NLM/NIH/HHS has endorsed" a product, and "only distribute data that are licensed for redistribution". Each article keeps its own license: https://pmc.ncbi.nlm.nih.gov/about/copyright/
- PubMedNLM's terms
Cellosaurus, SIB Swiss Institute of Bioinformatics, https://www.cellosaurus.org, CC BY 4.0. Its problem notes are given in its own words.
For software
Read this cell line from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/cell-lines/v1/CVCL_3798
GET https://conductscience.org/api/cell-lines/v1/CVCL_3798/papers?page=2